FAS and neoplasm: Asunercept (APG101/CAN008), an inhibitor of the CD95/CD95L signaling pathway, effectively suppressed the CD95L-increased cell invasion in GBM cells and reduced tumor invasion into surrounding tissues in intracranial xenograft mouse models, and it prolonged mouse survival [16,18].